Public Calendar: March 20-26, 2022
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs
No Significant Event
Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner
Event Date: 03/25/2022
Location: Virtual
Subject: Membership Meeting of the National Academies Forum on Drug Discovery, Development, and Translation
FDA Participant/Group: KEVIN BUGIN;
Non FDA Participant/Group: Representatives from federal agencies, industry, academia, nonprofit and advocacy organizations, and invited speakers
Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response
Event Date: 03/23/2022
Location: Virtual
Subject: New Era of Smarter Food Safety Update, University of Georgia, Center for Food Safety Annual Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Food safety experts from the food industry, academia, and government
Event Date: 03/23/2022
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Several Western Growers Association Food Safety, Science and Technology Board Committee members
Event Date: 03/24/2022
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Several staff and members of the California and Arizona Leafy Greens Handler Marketing Agreement
Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy
Event Date: 03/21/2022
Location: Virtual
Subject: Steering Committee Meeting of the Member State Mechanism on Substandard and Falsified Medical Products
FDA Participant/Group: RUSSELL CAMPBELL, JOSEPH RIERAS, LEAH HSU-LUFTMAN, LEIGH VERBOIS, CHAHAL HARINDEER
Non FDA Participant/Group: Steering committee members
Event Date: 03/22/2022
Location: Virtual
Subject: International Agency for Research on Cancer Regarding Aspartame Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the International Agency for Research on Cancer
Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Erica Jefferson, Associate Commissioner for External Affairs
No Significant Event
Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist
No Significant Event
Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research
Event Date: 03/23/2022
Location: Virtual
Subject: International Coalition of Medicines Regulatory Authorities (ICMRA) Executive Committee Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the International Coalition of Medicines Regulatory Authorities
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 03/22/2022
Location: Virtual
Subject: Postmortem of Two Success Stories: The Extraordinary Success of the COVID Vaccine and Drug Development Programs - What Went Right with Warp Speed?
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the National Institutes of Health / National Institute on Aging’s Development of Function Promoting Therapies: Public Health Need, Molecular Targets, and Drug Development Workshop
Event Date: 03/24/2022
Location: Virtual
Subject: Town Hall Participant: Helping Patients Navigate Regenerative Medicine and Cell and Tissue-Based Therapies
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Alliance for Cell Therapy Now / National Football League Alumni Health Town Hall
Event Date: 03/24/2022
Location: Virtual
Subject: Columbia University Course Lecture: FDA, It's Regulations, and COVID-19
FDA Participant/Group: N/A
Non FDA Participant/Group: Select students at Columbia University
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
Event Date: 03/22/2022
Location: Virutal
Subject: Duke Margolis Center for Health Policy, Artificial Intelligence/Machine Learning; Fireside Chat: Regulation, Development, and Real-World Performance Evaluation Webinar
FDA Participant/Group: LINDA RICCI; MATTHEW DIAMOND; VINAY PAI; NICHOLAS PETRICK;
Non FDA Participant/Group: Members of industry involved in regulating artifical intelligence (AI), development of Good Machine Learning Practices, and post-market evaluation of Artificial Intelligence / Machine Learning (AI/ML) based software as a medical device
Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
Event Date: 03/22/2022
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: WILLIAM FLYNN; GREGORY TYSON; ANTONIA MONIQUE SENNETT;
Non FDA Participant/Group: Representatives of the United States Animal Health Association and American Association of Veterinary Laboratory Diagnosticians
Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research
No Significant Event
Official Name: Mark Raza, J.D., Chief Counsel
No Significant Event